1. A115 CLINICAL, RADIOGRAPHIC, AND ENDOSCOPIC REMISSION WITH VEDOLIZUMAB TREATMENT IN CROHN'S DISEASE. (1st March 2018) Authors: Kotze, P; Ma, C; Almutairdi, A; Al-Darmaki, A; Devlin, S; Kaplan, G G; Seow, C; Novak, K L; Lu, C; Ferraz, J; Stewart, M J; Buresi, M c; Mathivanan, M; Heatherington, J; Martin, M; Panaccione, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A116 LOSS OF RESPONSE TO VEDOLIZUMAB MAINTENANCE THERAPY IN CROHN`S DISEASE. (1st March 2018) Authors: Ma, C; Kotze, P; Almutairdi, A; Al-Darmaki, A; Devlin, S; Kaplan, G G; Seow, C; Novak, K L; Lu, C; Ferraz, J; Stewart, M J; Buresi, M c; Mathivanan, M; Heatherington, J; Martin, M; Panaccione, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A122 COMBINATION BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASE: THE CALGARY EXPERIENCE. (15th March 2019) Authors: Panaccione, N; Novak, K L; Seow, C; Devlin, S; Lu, C; Heatherington, J; Kaplan, G G; Panaccione, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A97 DEVELOPMENT OF PREDICTION MODELS FOR THE TRIAGING OF REFERRALS OF INDIVIDUALS WITH SUSPECTED INFLAMMATORY BOWEL DISEASE TO IMPROVE PROMPT ACCESS TO CARE. (21st February 2022) Authors: St-Pierre, J; Frolkis, A; Seow, C; Oshiomogho, J; Bindra, G; Heatherington, J; Kaplan, G G; Panaccione, R; Novak, K L; Nasser, Y; Jijon, H Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P703 Clinical, radiographic and endoscopic remission with vedolizumab treatment in Crohn's disease. (16th January 2018) Authors: Kotze, P G; Ma, C; Almutairdi, A; Al-Damarki, A; Devlin, S; Kaplan, G; Seow, C; Novak, K; Lu, C; Ferraz, J; Stewart, M; Buresi, M; Mathivanan, M; Jijon, H; Heatherington, J; Martin, M -L; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P717 The use of combination biologic therapy in inflammatory bowel disease: A single tertiary-centre experience. (25th January 2019) Authors: Panaccione, N; Novak, K; Seow, C; Devlin, S; Lu, C; Heatherington, J; Martin, M-L; Kaplan, G; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗